Integer Holdings Corporation (NYSE:ITGR) Shares Sold by Trust Point Inc.

Trust Point Inc. decreased its position in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 37.9% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,538 shares of the medical equipment provider's stock after selling 3,995 shares during the period. Trust Point Inc.'s holdings in Integer were worth $772,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Lee Danner & Bass Inc. bought a new position in shares of Integer in the fourth quarter worth about $27,000. AdvisorNet Financial Inc bought a new position in shares of Integer in the first quarter worth about $28,000. Opal Wealth Advisors LLC bought a new position in shares of Integer in the first quarter worth about $28,000. Sterling Capital Management LLC grew its holdings in shares of Integer by 472.9% in the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock worth $45,000 after purchasing an additional 279 shares during the last quarter. Finally, Principal Securities Inc. grew its holdings in shares of Integer by 31.2% in the fourth quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider's stock worth $85,000 after purchasing an additional 152 shares during the last quarter. Institutional investors own 99.29% of the company's stock.

Insider Activity at Integer

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the transaction, the chief executive officer now owns 47,000 shares in the company, valued at approximately $5,788,990. This represents a 87.82% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the transaction, the director now owns 22,170 shares in the company, valued at approximately $2,672,815.20. This trade represents a 28.23% decrease in their position. The disclosure for this sale can be found here. Insiders sold 362,434 shares of company stock valued at $44,577,115 in the last three months. 2.16% of the stock is owned by insiders.

Integer Stock Down 0.2%

Shares of ITGR stock traded down $0.21 during mid-day trading on Wednesday, hitting $118.86. 374,625 shares of the stock traded hands, compared to its average volume of 378,410. The stock has a market cap of $4.15 billion, a P/E ratio of 56.33, a P/E/G ratio of 1.02 and a beta of 0.98. The stock's fifty day moving average is $119.72 and its two-hundred day moving average is $127.13. Integer Holdings Corporation has a 52-week low of $104.93 and a 52-week high of $146.36. The company has a debt-to-equity ratio of 0.78, a current ratio of 3.40 and a quick ratio of 2.14.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to analyst estimates of $428.51 million. Integer had a net margin of 4.38% and a return on equity of 11.95%. The company's quarterly revenue was up 7.3% on a year-over-year basis. During the same period in the prior year, the firm posted $1.14 earnings per share. Equities analysts predict that Integer Holdings Corporation will post 6.01 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on ITGR shares. Wall Street Zen upgraded shares of Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. Citigroup raised shares of Integer from a "hold" rating to a "strong-buy" rating and upped their price objective for the stock from $133.00 to $140.00 in a research note on Thursday, May 22nd. Oppenheimer lowered shares of Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Benchmark lowered their price objective on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research note on Friday, April 25th. Finally, Truist Financial set a $150.00 price objective on shares of Integer and gave the stock a "buy" rating in a research note on Friday, April 25th. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $145.00.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.